5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation. Insights From a Patient-Level Pooled Analysis of 4 Randomized Trials Comparing Sirolimus-Eluting Stents With Bare-Metal Stents

Journal of the American College of Cardiology

Volumn 54, Issue 10, 2009, Pages 894-902

  Caixeta, Adriano ^a   Leon, Martin B ^a   Lansky, Alexandra J ^a   Nikolsky, Eugenia ^a   Aoki, Jiro ^a   Moses, Jeffrey W ^a   Schofer, Joachim ^b   Morice, Marie Claude ^c   Schampaert, Erick ^d   Kirtane, Ajay J ^a   Popma, Jeffrey J ^e   Parise, Helen ^a   Fahy, Martin ^a   Mehran, Roxana ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e St Elisabeth Medical Center   (United States)

Author keywords

drug eluting stent; long term; restenosis; stent; thrombosis

Indexed keywords

CYPHER; FIBRINOGEN RECEPTOR ANTAGONIST; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MALE; MORTALITY; PRIORITY JOURNAL; STENT THROMBOSIS;

AGED; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; STENTS; THROMBOSIS; TREATMENT OUTCOME;

EID: 68949175646     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.077     Document Type: Article

References (13)

1. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
3. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
4. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
5. Laskey W.K., Yancy C.W., and Maisel W.H. Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation 115 (2007) 2352-2357
6. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Schofer J., Schluter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
8. Schampaert E., Cohen E.A., Schluter M., et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
9. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
10. Daemen J., Kukreja N., van Twisk P.H., et al. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry. Am J Cardiol 101 (2008) 1105-1111
11. James S.K., Stenestrand U., Lindbäck J., et al., SCAAR Study Group. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 360 (2009) 1933-1945
12. Garg P., Normand S.L., Silbaugh T.S., et al. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation 118 (2008) 2277-2285 7p following 2285
13. Stettler C., Allemann S., Wandel S., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis (abstr). BMJ 337 (2008) a1331